Meta AnalysisID 6093
复方斑蝥胶囊联合化疗对结直肠癌影响的系统评价与Meta分析
CRD42021225323
Meta analysis was used to evaluate the clinical efficacy of compound cantharidin capsule combined with chemotherapy in the treatment of colorectal cancer.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6093
- Evidence Id
- 14651
- Core Evidence Id
- 14651
- Source Meta Analysis Id
- 6075
- Herb2 Meta Analysis Id
- HBMA006075
- Crd Id
- CRD42021225323
- Title
- Effect of compound Banmao capsule combined with chemotherapy on colorectal cancer: systematic review and Meta analysis
- Review Question
- Meta analysis was used to evaluate the clinical efficacy of compound cantharidin capsule combined with chemotherapy in the treatment of colorectal cancer.
- Study Type Included
- Randomized controlled trials (RCTs) will be included.
- Condition Being Studied
- Colorectal cancer is a malignant tumor of colorectal gland epithelium, also known as colorectal cancer, mainly with abdominal pain, diarrhea, stool blood, defecation habits and character changes and other symptoms.Is one of the top ten malignant tumors in China, its morbidity and mortality are ranked third, still rising year by year is one of the factors threatening the safety of human life, the main factors leading to death are closely related to metastasis. The compound cantharidae capsule is widely used in clinical adjuvant anti-tumor therapy. It is composed of 11 kinds of traditional Chinese medicine, such as cantharidae, ginseng and Scutellaria barbata, so on.
- Participant
- Patients diagnosed with colorectal cancer by imaging and pathology without contraindication to chemotherapy; age 23-77, age unlimited, sex, occupation, region, race
- Animal
- Human Disease Modelled
- Intervention
- The control group was chemotherapy, and the treatment group added compound cantharidae capsule on the basis of the control group. Compound cantharidae capsule manufacturer is unlimited, but the dose is 0.25 g/ capsules, twice a day, three capsules once.
- Comparator Control
- The control group was treated with chemotherapy and the treatment group was treated with compound Banmao capsule
- Main Outcome
- Evaluation criteria for WHO solid tumor Measures of effect Selection SMD/MD RR/OR, Continuity Variables for Two-Class Variables
- Outcome Measure
- Additional Outcome
- Related adverse reactions such as gastrointestinal reactions (nausea, vomiting, diarrhea), bone marrow suppression, alopecia, etc Measures of effect Selection SMD/MD RR/OR, Continuity Variables for Two-Class Variables.
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Humans
- Contact
- Qiuju Gong [email protected]
- Organisational Affiliation
- Guizhou University of Traditional Chinese Medicine
- Funding Source
- Tumour Inheritance and Scientific and Technological Innovation Talent Team in Guizhou Province.
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2020-12-09
- Registration Date
- 2021-01-09
- Anticipated Start Date
- 2020-12-10
- Anticipated Completion Date
- 2021-01-31
- Title Cn
- 复方斑蝥胶囊联合化疗对结直肠癌影响的系统评价与Meta分析
- Title En
- Effect of compound Banmao capsule combined with chemotherapy on colorectal cancer: systematic review and Meta analysis
- Bilingual Status
- complete